Reports Q3 revenue $70.45M, consensus $44.87M. “We have continued the steady transformation of Novavax (NVAX) and are proud of our progress this quarter,” said John Jacobs, President and Chief Executive Officer, Novavax. “This year we have relaunched the Company with a focus on R&D and partnerships intended to position us well for long-term growth and profitability.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVAX: